[[Vomiting]] is the most commonly cited [[side effect]] of piclamilast. It has proven difficult to separate the emetic side effects from the therapeutic benefits of several PDE4 inhibitors, including piclamilast.<ref>{{cite journal | author =  | year = 2007 | title = Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain | journal = European Journal of Pharmacology | volume = 573 | issue = 1–3 | pmid = 17658510| pages = 93–99 | url =  | format =  | accessdate = | doi = 10.1016/j.ejphar.2007.06.045 | last1 = Hirose | first1 = R. | last2 = Manabe | first2 = H. | last3 = Nonaka | first3 = H. | last4 = Yanagawa | first4 = K. | last5 = Akuta | first5 = K. | last6 = Sato | first6 = S. | last7 = Ohshima | first7 = E. | last8 = Ichimura | first8 = M. }}</ref>

 

